The reality is that these deals between brand-name and generic pharmaceutical companies delay the entry of generic medicines into the marketplace.
This is a very important hearing that we're having to learn more about pay-for-delay agreements.
I think they harm drug competition.
I worked hard to make sure that this notice and filing provision was included in that legislation.
In my opinion, they only end up keeping drug costs artificially high for consumers and the taxpaying public.
We should be doing all we can to see that the American consumer has access to lower-priced drugs.
According to the 2010 Federal Trade Commission report entitled 'Pay For Delay: How Drug Companies Payoffs Cost Consumers...
the 340B program is not intended to subsidize pharmacies that team up with covered entities to turn a profit.
We should be pleased that our country has made advances in race relations since the Voting Rights Act was passed.
Many people believe that Section 2 is the heart of the Voting Rights Act, unlike Section 5 that prohibits voter discrimi...
Every one of us, I do not care what our political alliances are, we should be totally opposed to suppressing votes.